top of page

Research Data

The Info You’re After

Healthcare Professionals: FAQ

Heart Disease:

Is the cardiovascular system a therapeutic target for cannabidiol ?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579247/

Characterization of cannabidiol induced vasorelaxation in human mesenteric arteries.

http://www.pa2online.org/abstracts/vol9issue3abst098p.pdf

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

https://www.ncbi.nlm.nih.gov/pubmed/17890433

Neurodegenerative Disorders

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?https://www.ncbi.nlm.nih.gov/pubmed/22625422

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

https://www.ncbi.nlm.nih.gov/pubmed/28190698


Cannabidiol as a Promising Strategy to Treat and Prevent Movement

Disorders?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958190/

Antidepressant, Anxietolytic, Substance Abuse Disorders, Addiction

Anti-Inflammatory, Pain

bottom of page